Email Updates

You are here

IPM 034

Status
Completed
Phase
I
Objective

An Open-label, Parallel-group Pharmacokinetic Trial in Healthy HIV-negative Women to Characterize the Release Profile of Dapivirine Delivered by a Silicone Matrix Ring (Ring 004), Containing 25 mg of Dapivirine, Over Various Ring Use Periods.

Prevention Option(s)
Microbicides
Arms and Assigned Interventions
Products
Dapivirine Ring
Trial Sponsors
International Partnership for Microbicides
November 2013
May 2014
Enrollment
40
18
Years
40
Years
Population
Women
Sites

Site(s)

Belgium